Medicare Part D spending exceeds $3 billion on GLP-1 drugs by 2027
Resolves: Official Medicare spending reports show GLP-1 drug costs exceeding $3 billion for 2027.
user-generated· price
Medicare Part D spending exceeds $3 billion on GLP-1 drugs by 2027
Market overview
Spending on GLP-1 weight-loss drugs under Medicare Part D will surpass $3 billion by 2027.
price prediction market
- Implied probability (Yes)
- 65%
- Closes
- 2027-12-31
About this prediction
Resolution criteria
Official Medicare spending reports show GLP-1 drug costs exceeding $3 billion for 2027.
Source: user-generated
More price markets
- Egyptian tourism stocks rise 20% within 6 months of discovery — 55% Yes
- FIFA World Cup 2026 viewership declines 5% YoY in U.S. by 2027-01-31 — 60% Yes
- Liverpool FC stock price will rise by at least 5% within 6 months of Hillsborough Law enactment — 60% Yes
- UK student accommodation demand drops 15% — 75% Yes
- 10-year Treasury yield to exceed 5.5% by year-end — 60% Yes
- S&P 500 fast-tracks SpaceX inclusion by July 2026 — 75% Yes
- Biotech stocks underperform S&P 500 by 5% in 6 months — 60% Yes
- Byzantine-era coin hoard from Dakhla oasis auctioned for over $500,000 by 2027 — 60% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…